there is no such thing as "excessive" variability due to the very construct of what is variable as you've already pointed out there is no absolute benchmark, there are only strongly observed and tested guidelines which have been in use for many decades (+the pre-MDS advent)
as we have had specialist and well-renowned Doctor Barry Snow who supervised and oversaw the trials we can consider everything required was in place ...and still is....
one other point quickly overlooked is the addition of Dr. Sue a specialist in PD and associative diseases...it is unlikely an addition to the company with such depth of (current) knowledge would be added if the company had any doubts on current
appears to me everyone agrees (and you argue that) we need a bigger sample size with more time to run another trial
...it is what it is
- Forums
- ASX - By Stock
- 1AI
- INHERENT PROBLEMS with pd trials using brain surgery
1AI
algorae pharmaceuticals limited
Add to My Watchlist
0.00%
!
0.5¢

INHERENT PROBLEMS with pd trials using brain surgery, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.436M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $3.804K | 760.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 4331823 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 3229885 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 4331823 | 0.005 |
12 | 9510208 | 0.004 |
6 | 7130302 | 0.003 |
3 | 3650009 | 0.002 |
5 | 6915013 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 3229885 | 5 |
0.007 | 4239995 | 6 |
0.008 | 227572 | 4 |
0.009 | 1664380 | 3 |
0.010 | 2204715 | 3 |
Last trade - 14.16pm 01/07/2025 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online